Meet The Screamers. After being a scientist in one form or another for 30 years and blogging about stem cells and other science for more than 10 years, I’ve seen a lot of science hype. However, some science hype goes above and beyond the usual level to outright smack readers in the face. It almost […]
Meet The Screamers Science Hype Awards Read More »
A solid new, blinded placebo-controlled Phase II study from the Duke Autism Center clearly shows no benefit of cord blood for autism. Surprisingly, the team has said they are encouraged by the results. As a result, they apparently will continue this kind of work anyway despite their data. In contrast, I see the data as a
Duke Autism Center trial: no benefit of cord blood for autism Read More »
Platelet Rich Plasma (PRP) has been around for a long time, but patients are often confused by it. In part the confusion arises from how it is marketed, which sometimes includes it being described as “stem cells”, which it is not. However, at times it can be as a therapy with stem cells or other
Dr. Drew Lansdown Platelet Rich Plasma (PRP) Interview Read More »
How can we scientists find ways to keep doing our research during the COVID19 pandemic even if it has nothing to do with the coronavirus? Also, how should those of us involved in science communication talk about the outbreak? At a more basic level, how can scientists try not to go bonkers during this dark
Scientists try not to lose it with their labs shut by the pandemic Read More »
A firm called Kimera labs just received an untitled letter from the FDA. The firm has been supplying non-FDA-approved exosomes to various customers including at least one stem cell clinic without sparking any obvious action from the agency, but on April 10th that changed with the letter, which in my view is quite serious. What
Kimera Labs FDA letter cites exosomes for COVID-19, more issues Read More »
The California Stem Cell Agency, better known by the acronym CIRM, has done a vast amount of good over the past decade and a half, and today it needs your help for the future. CIRM, which stands for the “California Institute for Regenerative Medicine”, has funded a huge array of stem cell and other research
Please take a couple minutes now to help fund future of CIRM Read More »
Should we call it stem cell synchronicity for stem cell supplier firm Invitrx? What was it about March 16? Sometimes strange things happen in the stem cell world such as last week on March 16 I wrote that the FDA needs to do more about unproven exosomes, and then on the same day a new FDA warning
‘Captain Kirk’ regenerative clinic supplier Invitrx gets long FDA warning letter Read More »
The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem cell and other clinics right now, but who knows what’s in the syringe? Also, people
FDA needs to act boldly on unproven exosome therapies Read More »
Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as
Liveyon is back (again) with unproven exosome product Read More »
The novel coronavirus and the disease it causes, COVID-19, have swept the world with few proven treatment options. Vaccines are only recently being rolled out the last 2 or so months, which gives some real hope. While the novel coronavirus-caused illness is generally a mild disease in kids (many of whom don’t even show symptoms),
The Niche COVID-19 updates & resources Read More »